Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Return on Assets (2016 - 2025)

Guided Therapeutics' Return on Assets history spans 14 years, with the latest figure at 0.03% for Q4 2025.

  • On a quarterly basis, Return on Assets fell 1.0% to 0.03% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.03%, a 1.0% decrease, with the full-year FY2025 number at 0.02%, down 1.0% from a year prior.
  • Return on Assets hit 0.03% in Q4 2025 for Guided Therapeutics, down from 0.03% in the prior quarter.
  • Over the last five years, Return on Assets for GTHP hit a ceiling of 0.01% in Q2 2021 and a floor of 0.03% in Q4 2025.
  • Historically, Return on Assets has averaged 0.02% across 5 years, with a median of 0.02% in 2024.
  • The widest YoY moves for Return on Assets: up 6bps in 2021, down -3bps in 2021.
  • Tracing GTHP's Return on Assets over 5 years: stood at 0.01% in 2021, then decreased by -18bps to 0.01% in 2022, then tumbled by -64bps to 0.02% in 2023, then rose by 6bps to 0.02% in 2024, then plummeted by -56bps to 0.03% in 2025.
  • Business Quant data shows Return on Assets for GTHP at 0.03% in Q4 2025, 0.03% in Q3 2025, and 0.03% in Q2 2025.